Evaluation of intravenous amoxicillin-clavulanate use in two Canadian hospitals
We describe our experience with intravenous amoxicillin-clavulanate, which is new to the Canadian market. The majority of patients were successfully de-escalated from piperacillin-tazobactam or a carbapenem for respiratory infections or skin and soft tissue infections. Intravenous amoxicillin-clavul...
Saved in:
Main Authors: | Maggie Wong (Author), Sangita Malhotra (Author), Kevin Afra (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients
by: Sarah A. Drost, et al.
Published: (2023) -
Bioequivalence of amoxicillin and clavulanic acid tablet
by: Yuwadee Sirisomboon
Published: (2006) -
Amoxicillin and clavulanate potassium related Leucocytoclastic vasculitis
by: Snehal Balvant Lunge, et al.
Published: (2014) -
Drug İnduced Autoimmune Hepatitis by Amoxicillin- Clavulanate
by: Ufuk BARIŞ KUZU, et al.
Published: (2016) -
Treatment of Cervical Chlamydial Infection With Amoxicillin/Clavulanate Potassium
by: Melinda S. Mann, et al.
Published: (1993)